BMO Capital on National Health Investors (NHI): 'Acquisitions Accelerating; SHOP Growth Execution Key'

September 23, 2026 8:54 AM

BMO Capital analyst Juan C. Sanabria reiterated an Outperform rating and $80.00 price target on National Health Investors (NYSE: NHI).The ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found